Recent Patents on Anti-Cancer Drug Discovery

Yeast-Derived β-Glucan in Combination with Anti-Tumor Monoclonal Antibody Therapy in Cancer
pp. 101-109(9)
Authors: Liu, Jingjing; Gunn, Lacey; Hansen, Richard; Yan, Jun

Targeting RhoA/Rho Kinase and p21-Activated Kinase Signaling to Prevent Cancer Development and Progression
pp. 110-124(15)
Authors: Chang, Yu-Wen E.; Bean, Ronald R.; Jakobi, Rolf

Ras-MAPK Pathway as a Therapeutic Target in Cancer - Emphasis on Bladder Cancer
pp. 125-136(12)
Authors: Dangle, Pankaj P.; Zaharieva, Boriana; Jia, Hongtao; Pohar, Kamal S.

Paving Roads for New Drugs in Oncology
pp. 137-145(9)
Authors: Zaenker, Kurt S.; Entschladen, Frank

Targeted Therapies in the Treatment of Advanced Renal Cell Carcinoma
pp. 146-156(11)
Authors: Seront, Emmanuel; Machiels, Jean-Pascal

Selective Cyclooxygenase-2 (COX-2) Inhibitors Used for Preventing or Regressing Cancer
pp. 157-163(7)
Author: Pereira, Ricardo d. S.

Basis for Resistance to Imatinib in 16 BCR-ABL Mutants as Determined Using Molecular Dynamics
pp. 164-173(10)
Authors: Lee, Tai-Sung; Potts, Steven J.; Albitar, Maher

Rationale for an Intraperitoneal Gemcitabine Chemotherapy Treatment for Patients with Resected Pancreatic Cancer
pp. 174-179(6)
Authors: Kamath, Anil; Yoo, Dal; Stuart, Oswald A.; Bijelic, Lana; Sugarbaker, Paul H.

Anti-Angiogenic Agents and Cancer: Current Insights and Future Perspectives
pp. 180-185(6)
Author: De Paepe, Boel

Patent Selections
pp. 186-188(3)
Author: Bentham Science Publishers